Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
41.46
-0.23 (-0.55%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
40.75
-0.71 (-1.72%)
Bozordan keyin: Jun 26, 2026, 7:20 PM EDT
Edgewise Therapeutics, Inc., biofarmatsevtika kompaniyasi, mushak kasalliklarini davolash uchun terapiyalarni kashf etadi, ishlab chiqadi va tijoratlashtiradi. Uning yetakchi mahsulot nomzodi, sevasemten, og'iz orqali yuboriladigan kichik molekula bo'lib, II bosqich klinik sinovlarida bo'lib, Duchenne mushak distrofiyasi va Bekker mushak distrofiyasi, shu jumladan distrofinopatiyalarning asosiy sababini bartaraf etish uchun mo'ljallangan. Kompaniya EDG-7500, gipertrofik kardiomiopatiya va boshqa og'ir yurak kasalliklarini davolash uchun kichik molekulani ishlab chiqadi, bu I bosqich klinik sinovlarida; va EDG-15400, saqlanib qolgan ejeksiyon fraktsiyasi bilan yurak etishmovchiligini davolash uchun yangi kichik molekulani ishlab chiqadi. Muxolif o'laroq, kompaniya genetik aniqlangan mushak kasalliklarini davolash uchun asosiy mushak oqsillari va modulyatorlariga qaratilgan aniq dori mahsulotlari nomzodlarining quvurini ishlab chiqadi. Kompaniya 2017 yilda tashkil etilgan va Boulder, Kolorado shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Alan J. Russell Ph.D. | Co-Founder, Chief Scientific Officer & Director |
| Dr. Badreddin Edris Ph.D. | Co-Founder & Independent Director |
| Dr. Behrad Derakhshan Ph.D. | Chief Operating Officer |
| Dr. Joanne M. Donovan M.D., Ph.D. | Chief Medical Officer |
| Dr. Kevin Koch Ph.D. | President, CEO & Director |
| Dr. Peter A. Thompson FACP, M.D. | Co-Founder & Independent Chairman |
| Mr. John R. Moore J.D. | General Counsel |
| Mr. Michael P. Nofi | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-05 | 8-K | tm2616953d1_8k.htm |
| 2026-06-01 | 8-K | d24037d8k.htm |
| 2026-05-07 | S-8 | tm2613274d1_s8.htm |
| 2026-05-07 | 10-Q | ewtx-20260331x10q.htm |
| 2026-04-23 | DEFA14A | ewtx-20260423xdefa14a.htm |
| 2026-04-23 | DEF 14A | ewtx-20260604xdef14a.htm |
| 2026-02-26 | 8-K | tm266859d1_8k.htm |
| 2025-11-20 | 8-K | tm2531112d1_8k.htm |
| 2025-11-10 | 8-K | tm2530663d1_8k.htm |
| 2025-11-06 | 8-K | tm2529979d1_8k.htm |